Surrey Heartlands

Joint Formulary & PAD

Atenolol - Arrhythmias

You are here : Home > Formulary Search > Atenolol - Arrhythmias

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Oral solution
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
 

Status 2

Red
Formulations :
  • Intravenous infusion
  • Intravenous injection (IV)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Atenolol
Indication :
Arrhythmias
Group Name :
Keywords :
beta-blockers
Brand Names Include :
Tenormin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Atenolol is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Arrhythmias.

Committee Recommendations (1)

03 May 17 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Atenolol has been considered by the PCN and has been assigned a GREEN traffic light status, within its LICENSED indication(s).

NOTE - the branded product (Tenormin) was considered BLACK at the PCN in May 2017.